Insurance for Life Science by Life Science Specialists

Whether in the United States or abroad, Berkley Life Sciences is solely dedicated to providing premiere insurance coverage for today’s top life sciences companies.

Download PDF

Who We Insure

We provide personalized property and casualty insurance products and services to the following life science markets:

Medical Device Companies

Companies that design, manufacture, and distribute medical instruments and devices for healthcare applications.

Medical Device Software Companies

Organizations that develop software solutions for use in union with medical devices to enhance functionality and patient outcomes.

Medical Drug Companies

Pharmaceutical firms involved in the research, development, manufacturing, and marketing of medications for treating various health conditions.

Biologic Companies

Companies that create biologically derived products, including vaccines, blood components, and gene therapies, for medical use.

Dietary Supplement Companies

Firms that produce and distribute vitamins, minerals, and other supplements intended to enhance health and wellness.

Medical Food Companies

Companies that develop and produce foods formulated explicitly for dietary management of diseases or conditions requiring medical supervision.

Cosmetic Drug Companies

Organizations that create products at the intersection of cosmetics and pharmaceuticals, designed to enhance appearance while providing therapeutic benefits.

Product Development Organizations

Companies offering specialized services in developing, testing, and regulatory approval of life science products.

Profit & Nonprofit R&D

Entities dedicated to conducting research in life sciences, ranging from private companies to academic and non-profit organizations.

Product Testing Laboratories

Laboratories specializing in the testing and validation of life science products, ensuring compliance with regulatory standards and safety requirements.

Medical Product Distributors

Companies that manage the distribution and supply chain logistics for a wide range of medical products, ensuring their availability to healthcare providers.

Drug Discovery Technology

Firms and organizations that develop technologies and methodologies to accelerate the identification and development of new pharmaceutical compounds.

Bioengineering

Companies and research institutions that apply biology and engineering principles to develop innovative solutions in healthcare, agriculture, and environmental management.

Health Informatics

Organizations specializing in the intersection of healthcare and information technology, providing solutions for managing and analyzing health data.

Non-Medical Biotechnology

Companies focused on biotechnology applications beyond healthcare, including agriculture, environmental management, and industrial processes.

Find a Berkley Life Sciences Agent

Ready for an insurance solution that is tailored to your life science business by life science specialists?

Find an Agent

The Latest in Life Science

Direct-to-Consumer Revolution in Digital Healthcare: Regulatory and Operational Challenges

The Direct-to-Consumer Revolution in Digital Healthcare: Regulatory and Operational Challenges

At my last doctor’s appointment, I learned how to use my smartwatch to perform an electrocardiogram (ECG) to test for atrial fibrillation. Naturally, I found myself checking my ECG multiple times a day, curious about the fluctuations in my heart rate. Did I have cause for concern? Fortunately, my watch consistently reported no evidence of atrial fibrillation, while also issuing a clear disclaimer that it could not detect signs of a heart attack.

Digital Twins in Medicine: Science Fiction or Modern Data Miracle?

The term “digital twin” may evoke images straight from the pages of science fiction, such as Nobel Prize winner Kazuo Ishiguro’s dystopian novel, Never Let Me Go, in which biological clones are raised solely for their organs. In reality, the concept of a digital twin in medicine—while still emerging—is no longer confined to fiction.

Ethylene Oxide & Medical Device Sterilization: A Litigation Overview

Last year, Berkley Life Sciences’ Blog featured an important post on Preventing Medical Device Shortages Through Improving the United States Sterilization Supply Chain. That article highlighted potential supply chain constraints caused in-part by sterilization facility shutdowns and regulatory requirements to install or upgrade emission control equipment. What that post did not address—and what this article will explore—is the nationwide litigation that has impacted the sterile medical device industry over the past five years.